Host Julien Poulain delves into the topic of Health Technology Assessments (HTAs) – the processes through which healthcare systems evaluate the available therapies and technologies for treating a condition. HTAs are central to healthcare systems determination of whether a particular treatment is worth paying for and should be reimbursed when accessed by patients.
Julien is joined by Johan De Graaf, President of the Dutch Pituitary Foundation (Nederlandse Hypofyse Stichting), who shares both his own and his community’s experiences with securing reimbursements for improved treatments. Johan also talks about patient-led efforts to expand access to these treatments.
François Houÿez, Information & Access to Therapies Director at EURORDIS, also joins to talk about the state of HTAs across Europe and why patients’ engagement with them is so important.
Learn more about the work that EURORDIS and partner organisations are undertaking to empower patient involvement in Health Technology Assessments through the European Capacity Building for Patients (EUCAPA) project: https://www.eurordis.org/eurordis-launches-eucapa/.
Contact the podcast by emailing RareOnAir@eurordis.org, and join the conversation on social media using the hashtag #EurordisRareOnAir.
